These revelations were made possible by a number of sophisticated advances achieved in the course of the study. In particular, Shatz developed ways of augmenting the activity of the Atg24-Atg20 complex and reducing the activity of the Atg2-Atg18 complex, rather than overexpressing or completely knocking out their genes, as is commonly done in molecular cell biology. In addition, he and his colleagues developed an innovative way of labeling several proteins with different colors within the same experiment.
The study’s findings contribute to an in-depth understanding of autophagy that in the future might open the way to medical applications. “If you want to fix a car, you need to know its parts and exactly what they do,” Elazar says. “Similarly, we need to arrive at a detailed knowledge of autophagy mechanisms to be able one day to tweak them to just the right levels in our bodies.”
Also taking part in the study were Dr. Milana Fraiberg, Damilola Isola, Dr. Shubhankar Das, Dr. Olee Gogoi and Dr. Alexandra Polyansky from the Biomolecular Sciences Department; and the late Dr. Eyal Shimoni, Dr. Tali Dadosh, Dr. Nili Dezorella and Dr. Sharon G. Wolf of the Chemical Research Support Department.


